Breath-hold MRI test to measure liver scar levels
Part of Digestive system clinical trials.
This study tests an MRI technique that briefly holds your breath to measure how scarred your liver tissue is. It may help doctors better spot and track liver fibrosis (scarring).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- If you join the patient group, you have liver fibrosis confirmed by a liver biopsy
- If you join the control group, you are an adult without the study’s liver fibrosis diagnosis
- You must be able to safely have an MRI scan
- You cannot have MRI safety issues like a pacemaker or certain metal implants
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special MRI scan (called 4D-MRI) can identify liver scarring or damage. It may help doctors measure liver fibrosis and inflammation without relying only on invasive tests.
This study uses a special type of MRI scan to see how well treatment for lung scarring (pulmonary fibrosis) is working. It may help doctors understand if the medication you're taking is helping your lungs.
This study tests whether breathing pure oxygen during an MRI scan can help patients hold their breath longer and produce better images of the liver. It might make the scan more comfortable and reliable for people who have trouble holding their breath.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
This study uses a special MRI scan to measure blood flow in the liver and detect liver damage. Researchers are testing whether this new imaging method can help diagnose liver disease early and track how well treatments are working.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
Hear when a new Liver Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.